Drug-drug interactions (DDIs) severity assessment is a crucial problem because
polypharmacy is increasingly common in modern medical practice. Many DDIs are caused …

Simultaneous use of the drugs may lead to undesirable Drug-Drug Interactions (DDIs) in the
human body. Many DDIs are associated with changes in drug metabolism that performed by …

Prediction of in vivo drug-drug interactions (DDIs) from in vitro and in vivo data, also named
in vitro in vivo extrapolation (IVIVE), is of interest to scientists involved in the discovery and …

Abstract Background and Objective Pharmacokinetic drug-drug interactions (DDIs) are one
of the major causes of adverse events in pharmacotherapy, and systematic prediction of the …

Drug-drug interaction (DDI) is the phenomenon of alteration of the pharmacological activity
of a drug (s) when another drug (s) is co-administered in cases of so-called polypharmacy …

Adverse drug reaction is a frequent cause of drug withdrawals from the market. The drug-
drug interaction (DDI) potential of new drug candidates is an increasing safety concern of …

The characterization of drug-drug interactions (DDIs) may require the use of several different
tools, such as the thesaurus issued by our national health agency (ie, ANSM), the metabolic …

An external file that holds a picture, illustration, etc. Object name is bi-6-71-g008. jpg
Introduction: Health care industry also patients penalized by medical errors that are …

Drug–drug interactions (DDIs) can cause drug toxicities, reduced pharmacological effects,
and adverse drug reactions. Studies aiming to determine the possible DDIs for an …

The majority of Americans, accounting for 51% of the population, take 2 or more drugs daily.
Unfortunately, nearly 100,000 people die annually as a result of adverse drug reactions …